James Healy Natera, Inc. (NTRA) insider trading activity

NTRA Quotes by TradingView

James Healy is of Natera, Inc.. Currently has a direct ownership of 46,118 shares of NTRA, which is worth approximately $7.49 Million. The most recent transaction as insider was on Jan 31, 2025, when has been sold 114 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.1K
0.25% 3M change
8.51% 12M change
Total Value Held $7.49 Million

JAMES HEALY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2025
BUY
Grant, award, or other acquisition
-
114 Added 0.25%
46,118 Common Stock
Oct 25 2024
BUY
Grant, award, or other acquisition
-
153 Added 0.33%
46,004 Common Stock
Jul 26 2024
BUY
Grant, award, or other acquisition
-
177 Added 0.38%
45,851 Common Stock
Jun 28 2024
BUY
Grant, award, or other acquisition
-
2,964 Added 6.09%
45,674 Common Stock
Apr 26 2024
BUY
Grant, award, or other acquisition
-
210 Added 0.49%
42,710 Common Stock
Jan 26 2024
BUY
Grant, award, or other acquisition
$16,840 $63.79 p/Share
264 Added 0.62%
42,500 Common Stock
Oct 27 2023
BUY
Grant, award, or other acquisition
$16,869 $42.6 p/Share
396 Added 0.93%
42,236 Common Stock
Jul 28 2023
BUY
Grant, award, or other acquisition
$15,901 $48.48 p/Share
328 Added 0.78%
41,840 Common Stock
Jun 30 2023
BUY
Grant, award, or other acquisition
-
2,750 Added 6.21%
41,512 Common Stock
May 25 2023
BUY
Exercise of conversion of derivative security
-
3,534 Added 8.36%
38,762 Common Stock
Apr 14 2023
BUY
Grant, award, or other acquisition
$15,598 $54.73 p/Share
285 Added 0.8%
35,228 Common Stock
Jan 13 2023
BUY
Grant, award, or other acquisition
$15,603 $40.01 p/Share
390 Added 1.1%
34,943 Common Stock
Oct 14 2022
BUY
Grant, award, or other acquisition
$15,624 $45.42 p/Share
344 Added 0.99%
34,553 Common Stock
May 25 2022
BUY
Exercise of conversion of derivative security
-
1,307 Added 3.73%
33,779 Common Stock
May 28 2021
BUY
Exercise of conversion of derivative security
-
2,856 Added 8.08%
32,472 Common Stock

Also insider at

HGEN
HUMANIGEN, INC Healthcare
Director
CHRS
Coherus BioSciences, Inc. Healthcare
Director
BOLT
Bolt Biotherapeutics, Inc. Healthcare
YMAB
Y-mAbs Therapeutics, Inc. Healthcare
Director
KRTX
Karuna Therapeutics, Inc. Healthcare
CINC
CinCor Pharma, Inc. Healthcare
Director
AVBP
ArriVent Biopharma, Inc.
Director
RAPP
Rapport Therapeutics, Inc.
Director
BIOA
BioAge Labs, Inc.
JH

James Healy

Menlo Park, CA

Track Institutional and Insider Activities on NTRA

Follow Natera, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTRA shares.

Notify only if

Insider Trading

Get notified when an Natera, Inc. insider buys or sells NTRA shares.

Notify only if

News

Receive news related to Natera, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NTRA